OncoTherics is a new pharmaceutical company, focusing on the development of novel hypoxia-activated pro-drugs for the treatment of a wide range of cancers...
The company was formed as a spin-out from BioStatus, to progress a novel small molecule, code-named OCT1002. The company is at an early stage but the patented technology has a unique history allowing a more rapid than usual progression through the clinical trial process. For further information, please contact us using the contact form provided on this site ...
Company Details
- Employees
- 6
- Founded
- -
- Address
- Ul. Prof. Michała Bobrzyńskiego 14, Kraków,30-348,poland
- Phone
- +44 1509 558 163
- en****@****ics.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- oncotherics.com
- HQ
- Kraków
Oncotherics Questions
Oncotherics's helpline number is +44 1509 558 163
Oncotherics's website is oncotherics.com
Oncotherics's LinkedIn profile is https://uk.linkedin.com/company/oncotherics-limited
Oncotherics has
6 employees.
View email and phone details for 6
employees at Oncotherics.
Oncotherics's industry is
Pharmaceutical Manufacturing
Oncotherics's top competitors are
Biostatus Limited,
Akigai,
Nanotherics, Ltd,
New Amsterdam Sciences, Inc,
Onena Medicines,
Biosuspensions Limited,
Temisis Therapeutics,
Carabao,
Apaxen,
Oncotherx.
Oncotherics's support email address is enquiry@oncotherics.com
Oncotherics's categories are Pharmaceutical Manufacturing
Oncotherics's founding year is 2009
